Only 1 in 3 adults with diabetes in South-East Asia get treatment, and under 15% control blood sugar. WHO urges stronger, ...
Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback